Stroma Medical Corporation catapulted into the national spotlight in 2011 after revealing a laser device it claimed could ...
Ophthalmologists have raised concerns about a bill in the New Hampshire State House that would expand laser treatment certifications for optometrists, according to a Dec. 9 report from ABC affiliate ...
Eye doctors are in a big fight at the New Hampshire State House over who can perform certain laser procedures to treat ...
ViaLase announced the first patient has been treated in its US-based Investigational Device Exemption (IDE) clinical trial ...
Stead added that while SLT is now the first treatment that is offered to patients, a range of topical medications in the form ...
ViaLase, Inc., a clinical-stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced that the first patient has been treated in its U.S.
CHICAGO -- Upfront laser trabeculoplasty significantly slowed glaucoma progression and vision loss as compared with eye drops, long-term follow-up from a large randomized trial showed. After 6 years ...
Selective laser trabeculoplasty lowers intraocular pressure (IOP) by more than 20% in patients using topical IOP-lowering agents. “[S]elective laser trabeculoplasty (SLT) has become an alternative ...
SLT is emerging as a cost-effective first-line treatment, offering superior intraocular pressure stability compared to traditional eye drops. Minimally invasive glaucoma surgeries, like the iStent ...
GENEVA--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care, dedicated to helping people see brilliantly, announced today the full U.S. commercial availability of Voyager™ DSLT, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback